The effect of levetiracetam on high-frequency oscillations in patients with AD and epilepsy shows its potential as a biomarker for disease detection.

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

The latest trading day saw Vertex Pharmaceuticals (VRTX) settling at $503.20, representing a -1.37% change from its previous close. Amicus Therapeutics (FOLD) reported earnings 30 days ago.

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

A novel study has shed new light on the brain structures critical to human verbal memory, offering valuable insights for ...

This study builds on previous findings showing modular organization of primate visual cortical areas by presenting important results about the cortical processing of color, disparity, and naturalistic ...

After hours: March 21 at 7:13:50 PM EDT Loading Chart for VRTX ...